Aktis Oncology, Inc. (AKTS)
NASDAQ·Healthcare·Biotechnology
$20.05
-9.18%
Mkt Cap $1.21B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (4 analysts)
$35.33
Range $31.00 – $40.00
Implied Upside
+76.2%
Consensus $35.33 vs current $20.05
NASDAQ·Healthcare·Biotechnology
$20.05
-9.18%
Mkt Cap $1.21B
Buy
3
Hold
0
Sell
0
Price Target (4 analysts)
$35.33
Range $31.00 – $40.00
+76.2%
Consensus $35.33 vs current $20.05